GB201016880D0 - Phosphodiesterase inhibitors - Google Patents
Phosphodiesterase inhibitorsInfo
- Publication number
- GB201016880D0 GB201016880D0 GBGB1016880.5A GB201016880A GB201016880D0 GB 201016880 D0 GB201016880 D0 GB 201016880D0 GB 201016880 A GB201016880 A GB 201016880A GB 201016880 D0 GB201016880 D0 GB 201016880D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- phosphodiesterase inhibitors
- phosphodiesterase
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1016880.5A GB201016880D0 (en) | 2010-10-07 | 2010-10-07 | Phosphodiesterase inhibitors |
PCT/GB2011/051872 WO2012046030A2 (en) | 2010-10-07 | 2011-10-03 | Phosphodiesterase inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1016880.5A GB201016880D0 (en) | 2010-10-07 | 2010-10-07 | Phosphodiesterase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201016880D0 true GB201016880D0 (en) | 2010-11-17 |
Family
ID=43243648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1016880.5A Ceased GB201016880D0 (en) | 2010-10-07 | 2010-10-07 | Phosphodiesterase inhibitors |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201016880D0 (en) |
WO (1) | WO2012046030A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
JP5992054B2 (en) | 2011-11-29 | 2016-09-14 | ノバルティス アーゲー | Pyrazolopyrrolidine compound |
JO3357B1 (en) | 2012-01-26 | 2019-03-13 | Novartis Ag | Imidazopyrrolidinone compounds |
US9365576B2 (en) | 2012-05-24 | 2016-06-14 | Novartis Ag | Pyrrolopyrrolidinone compounds |
EP2948453B1 (en) | 2013-01-22 | 2017-08-02 | Novartis AG | Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction |
WO2014115077A1 (en) | 2013-01-22 | 2014-07-31 | Novartis Ag | Substituted purinone compounds |
CN103819476B (en) * | 2013-03-05 | 2016-08-17 | 中国人民解放军第二军医大学 | Pyrrolidone pyrazole compound and the purposes as medicine thereof |
MX2015016344A (en) | 2013-05-27 | 2016-03-01 | Novartis Ag | Imidazopyrrolidinone derivatives and their use in the treatment of disease. |
US8975417B2 (en) | 2013-05-27 | 2015-03-10 | Novartis Ag | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |
CA2912986A1 (en) * | 2013-05-28 | 2014-12-04 | Novartis Ag | Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease |
AU2014272700B2 (en) | 2013-05-28 | 2016-12-01 | Novartis Ag | Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease |
WO2015075665A1 (en) | 2013-11-21 | 2015-05-28 | Novartis Ag | Pyrrolopyrrolone derivatives and their use as bet inhibitors |
CN104876936B (en) * | 2015-05-25 | 2018-01-30 | 中国人民解放军第二军医大学 | The preparation of pyrrolones and pyrazole compound and the purposes as medicine |
BR112020012374A2 (en) * | 2017-12-22 | 2020-11-24 | Chemocentryx, Inc. | diaryl-substituted 5.5-fused ring compounds as c5ar inhibitors |
EP3936192A4 (en) * | 2019-03-06 | 2022-11-16 | Daiichi Sankyo Company, Limited | Pyrrolopyrazole derivative |
CN112142742B (en) * | 2019-06-26 | 2022-01-07 | 香港理工大学深圳研究院 | CTCF transcription factor inhibitor and application thereof |
WO2022155860A1 (en) * | 2021-01-21 | 2022-07-28 | Biofront Therapeutics (Beijing) Co., Ltd. | Modulators of fpr1 and methods of using the same |
WO2022155859A1 (en) * | 2021-01-21 | 2022-07-28 | Beijing Tiantan Hospital | Modulators of fpr1 and methods of using the same |
GB202100976D0 (en) | 2021-01-25 | 2021-03-10 | Riotech Pharmaceuticals Ltd | Treatment |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4356108A (en) | 1979-12-20 | 1982-10-26 | The Mead Corporation | Encapsulation process |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US5508300A (en) * | 1994-01-14 | 1996-04-16 | Pfizer Inc. | Dihydro pyrazolopyrroles, compositions and use |
RU2320661C2 (en) * | 2006-03-15 | 2008-03-27 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию Российской Федерации" (ГОУ ВПО ПГФА Росздрава) | 1,4,5,6-tetrahydro-6-oxo-5-(2-piperazinoethyl)-4-phenyl-3-(4-chlorophenyl)pyrrolo[3.4-c]pyrazole dihydrochloride eliciting hypotensive and anti-coagulant activity |
CA2682473A1 (en) * | 2007-03-30 | 2008-10-09 | Shionogi & Co., Ltd. | Novel pyrrolinone derivative and pharmaceutical composition comprising the same |
TW201016702A (en) * | 2008-09-25 | 2010-05-01 | Shionogi & Co | Novel pyrrolinone derivative and pharmaceutical composition comprising the same |
CA2686584A1 (en) * | 2009-11-27 | 2011-05-27 | Institut Pasteur | Plasmodium proteases inhibitors and in silico screening methods for identifying the same |
-
2010
- 2010-10-07 GB GBGB1016880.5A patent/GB201016880D0/en not_active Ceased
-
2011
- 2011-10-03 WO PCT/GB2011/051872 patent/WO2012046030A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012046030A3 (en) | 2012-08-09 |
WO2012046030A2 (en) | 2012-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254345B (en) | Cdk inhibitors | |
GB201016880D0 (en) | Phosphodiesterase inhibitors | |
HK1201519A1 (en) | Inhibitors of phosphodiesterase type 10a 10a | |
EP2552208A4 (en) | Imidazolyl-imidazoles as kinase inhibitors | |
GB2498145B (en) | Releasable corrosion inhibitors | |
HK1200828A1 (en) | Kinase inhibitors | |
EP2683693A4 (en) | Rorgammat inhibitors | |
EP2710007A4 (en) | Kinase inhibitors | |
EP2552211A4 (en) | Indazolyl-pyrimidines as kinase inhibitors | |
EP2552214A4 (en) | Pyrazolyl-pyrimidines as kinase inhibitors | |
GB201009731D0 (en) | Kinase inhibitors | |
EP2785183A4 (en) | Triazolopyridinone pde10 inhibitors | |
EP2702064A4 (en) | Kinase inhibitors | |
HK1199873A1 (en) | Kinase inhibitors | |
PT3070091T (en) | Benzodioxole derivatives as phosphodiesterase inhibitors | |
EP2521451A4 (en) | Hedgehog inhibitors | |
EP2629616A4 (en) | Substituted amino-triazolyl pde10 inhibitors | |
GB201020798D0 (en) | Corrosion inhibitors | |
ZA201208111B (en) | Cytokine inhibitors | |
EP2642856A4 (en) | Integrin-linked kinase inhibitors | |
GB201018597D0 (en) | Inhibitors | |
GB201006605D0 (en) | Novel inhibitors | |
GB201003936D0 (en) | Novel inhibitors | |
GB201003502D0 (en) | Novel inhibitors | |
GB201120474D0 (en) | Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |